...
首页> 外文期刊>Journal of gastroenterology >Oral steroid versus steroid pulse therapy for autoimmune pancreatitis: Time to introduce new weapons
【24h】

Oral steroid versus steroid pulse therapy for autoimmune pancreatitis: Time to introduce new weapons

机译:口服类固醇与类固醇脉冲疗法治疗自身免疫性胰腺炎:是时候引入新武器了

获取原文
获取原文并翻译 | 示例

摘要

Sir,Autoimmune pancreatitis (AIP) was first described by Sarles et al. in 1961 in a patient with pancreatitis and hypergammaglobulinemia. However, Yoshida et al. used the term autoimmune pancreatitis for the first time. The Mayo Clinic and Japanese Pancreas Society have proposed criteria based on the histology, imaging, serology, and other organ involvement that are generally used to diagnose AIP. A constellation of elevated IgG4 level, lym-phoplasmacytic sclerosing pancreatitis in histology, and other organ involvement such as cholangitis and tubulo-interstitial nephritis may raise suspicion of AIP.
机译:主席先生,Sarles等人首先描述了自身免疫性胰腺炎(AIP)。 1961年,一名患有胰腺炎和高球蛋白血症的患者。然而,吉田等。首次使用术语自身免疫性胰腺炎。梅奥诊所和日本胰腺学会提出了基于组织学,影像学,血清学和其他通常用于诊断AIP的器官参与的标准。 IgG4水平升高,组织学上的淋巴胞浆性硬化性胰腺炎以及其他器官受累(如胆管炎和肾小管间质性肾炎)可能会引起对AIP的怀疑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号